Literature DB >> 28902776

Pancreatic Cancer Arising From the Remnant Pancreas: Is It a Local Recurrence or New Primary Lesion?

Daisuke Hashimoto1, Akira Chikamoto, Toshiro Masuda, Shigeki Nakagawa, Katsunori Imai, Yo-Ichi Yamashita, Howard A Reber, Hideo Baba.   

Abstract

Local recurrence of pancreatic cancer (PC) can occur in the pancreatic remnant. In addition, new primary PC can develop in the remnant. There are limited data available regarding this so-called remnant PC. The aim of this review was to describe the characteristics and therapeutic strategy regarding remnant PC. A literature search was performed using Medline published in English according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The incidence of remnant PC has been reported to be 3% to 5%. It is difficult to distinguish local recurrence from new primary PC. Genetic diagnosis such as Kirsten rat sarcoma viral oncogene homolog mutation may resolve this problem. For patients with remnant PC, repeated pancreatectomy can be performed. Residual total pancreatectomy is the most common procedure. Recent studies have described the safety of the operation because of recent surgical progress and perioperative care. The patients with remnant PC without distant metastasis have shown good long-term outcomes, especially those who underwent repeated pancreatectomy. Adjuvant chemotherapy may contribute to longer survival. In conclusion, this review found that both local recurrence and new primary PC can develop in the pancreatic remnant. Repeated pancreatectomy for the remnant PC is a feasible procedure and can prolong patient survival.

Entities:  

Mesh:

Year:  2017        PMID: 28902776     DOI: 10.1097/MPA.0000000000000897

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  4 in total

1.  Pancreatic cancer arising from the remnant pancreas after pancreatectomy: a multicenter retrospective study by the Kyushu Study Group of Clinical Cancer.

Authors:  Daisuke Hashimoto; Kota Arima; Shigeki Nakagawa; Yuji Negoro; Toshihiko Hirata; Masahiko Hirota; Masafumi Inomata; Kengo Fukuzawa; Takefumi Ohga; Hiroshi Saeki; Eiji Oki; Yo-Ichi Yamashita; Akira Chikamoto; Hideo Baba; Yoshihiko Maehara
Journal:  J Gastroenterol       Date:  2018-12-04       Impact factor: 7.527

2.  Prediction of Recurrence Pattern of Pancreatic Cancer Post-Pancreatic Surgery Using Histology-Based Supervised Machine Learning Algorithms: A Single-Center Retrospective Study.

Authors:  Koki Hayashi; Yoshihiro Ono; Manabu Takamatsu; Atsushi Oba; Hiromichi Ito; Takafumi Sato; Yosuke Inoue; Akio Saiura; Yu Takahashi
Journal:  Ann Surg Oncol       Date:  2022-03-01       Impact factor: 5.344

3.  Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases.

Authors:  Ashton A Connor; Robert E Denroche; Gun Ho Jang; Mathieu Lemire; Amy Zhang; Michelle Chan-Seng-Yue; Gavin Wilson; Robert C Grant; Daniele Merico; Ilinca Lungu; John M S Bartlett; Dianne Chadwick; Sheng-Ben Liang; Jenna Eagles; Faridah Mbabaali; Jessica K Miller; Paul Krzyzanowski; Heather Armstrong; Xuemei Luo; Lars G T Jorgensen; Joan M Romero; Prashant Bavi; Sandra E Fischer; Stefano Serra; Sara Hafezi-Bakhtiari; Derin Caglar; Michael H A Roehrl; Sean Cleary; Michael A Hollingsworth; Gloria M Petersen; Sarah Thayer; Calvin H L Law; Sulaiman Nanji; Talia Golan; Alyssa L Smith; Ayelet Borgida; Anna Dodd; David Hedley; Bradly G Wouters; Grainne M O'Kane; Julie M Wilson; George Zogopoulos; Faiyaz Notta; Jennifer J Knox; Steven Gallinger
Journal:  Cancer Cell       Date:  2019-01-24       Impact factor: 31.743

Review 4.  Is Laparoscopic Pancreaticoduodenectomy Feasible for Pancreatic Ductal Adenocarcinoma?

Authors:  Chang Moo Kang; Woo Jung Lee
Journal:  Cancers (Basel)       Date:  2020-11-18       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.